We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Fatty Acid Levels Could Help Predict Psychosis Risk

By HospiMedica International staff writers
Posted on 03 Nov 2016
Print article
Image: The Scream by Edvard Munch (Photo courtesy of the National Gallery in Oslo, Norway).
Image: The Scream by Edvard Munch (Photo courtesy of the National Gallery in Oslo, Norway).
A novel probabilistic model that combines history, clinical assessment, and fatty-acid biomarkers could help predict transition to first-episode psychosis, claims a new study.

Researchers at the University of Adelaide (UA; Australia), the Medical University of Vienna (Austria), and other institutions conducted a study in 40 patients in Austria to explore if a probabilistic model that combine medical historical, clinical risk factors, oxidative stress and cell membrane fatty acids biomarkers, and resting quantitative electroencephalography (qEEG), could improve the identification of patients with ultra-high risk (UHR) of psychosis.

The researchers then analyzed concurrent and baseline data of the study cohort, who overall exhibited a 28% one-year transition rate to psychosis. They then clustered several significant variables into historical (history of drug use), clinical (Positive and Negative Symptoms Scale [PNSS] and Global Assessment of Function [GAF] scores), and biomarker (total omega-3, nervonic acid) groups, and calculated the post-test probability of transition for each group separately and for group combinations, using the odds ratio form of Bayes’ rule.

The results showed that the combination of all three variable groups vastly improved the specificity of prediction. The model identified over 70% of UHR patients who transitioned within one year, compared with 28% identified by standard UHR criteria. The model classified 77% of cases as very high or low risk based on history and clinical assessment, suggesting that a staged approach, which reserved fatty-acid markers for 23% of cases remaining at intermediate probability following bedside interview, could be the most efficient. The study was published on September 20, 2016, in the Translational Psychiatry.

“Currently, all patients in the ultra-high risk group are considered to have a similar chance of a future psychotic episode; however, we have been able to identify high, intermediate and low-risk groups. The model may help clinicians to decide when a patient's risk of psychosis outweighs any side effects of treatment,” said lead author psychiatrist Scott Clark, MD, of the University of Adelaide. “Fatty acids such as omega-3 and nervonic acid are critical for the normal functioning of the brain, and low levels have been associated with the development of psychosis in high-risk groups.”

The concept of clinical UHR for psychosis was developed to facilitate early detection and intervention, and is defined by a cluster of subthreshold psychotic symptoms. These can include perceptions, such as hallucinations; thinking - for example, ideas of reference, odd beliefs, or magical thinking; and trait risk factors like a family history of psychosis. These are accompanied by impairment in day-to-day function. In recent meta-analysis, studies show that less than 30% of UHR patients will have transitioned to psychosis three years after identification.

Related Links:
University of Adelaide
Medical University of Vienna
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Forceps
BiClamp LAP

Print article

Channels

Surgical Techniques

view channel
Image: NTT and Olympus have begun the world\'s first joint demonstration experiment of a cloud endoscopy system (Photo courtesy of Olympus)

Cloud Endoscopy System Enables Real-Time Image Processing on the Cloud

Endoscopes, which are flexible tubes inserted into the body's natural openings for internal examination and biopsy collection, are becoming increasingly vital in medical diagnostics. Their minimal invasiveness... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.